Literature DB >> 7096997

The emerging story of a human parvovirus-like agent.

M J Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7096997      PMCID： PMC2134170          DOI： 10.1017/s0022172400070480

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN： 0022-1724


× No keyword cloud information.
  9 in total

1.  A small virus in human faeces.

Authors:  W K Paver; C R Ashley; E O Caul; S K Clarke
Journal:  Lancet       Date:  1973-02-03       Impact factor: 79.321

2.  Control of communicable diseases by age-specific immunization schedules.

Authors:  R M Anderson; R M May
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

3.  Febrile illness due to a parvovirus.

Authors:  J M Shneerson; P P Mortimer; E M Vandervelde
Journal:  Br Med J       Date:  1980-06-28

4.  Comparison of human fecal and serum parvo-like viruses.

Authors:  W K Paver; S K Clarke
Journal:  J Clin Microbiol       Date:  1976-07       Impact factor: 5.948

5.  Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent.

Authors:  G R Serjeant; J M Topley; K Mason; B E Serjeant; J R Pattison; S E Jones; R Mohamed
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

6.  The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent.

Authors:  M J Anderson; L R Davis; S E Jones; J R Pattison; G R Serjeant
Journal:  J Hyg (Lond)       Date:  1982-04

7.  Total screening of blood donations for Australia (hepatitis associated) antigen and its antibody.

Authors:  J Wallace; G R Milne; A Barr
Journal:  Br Med J       Date:  1972-03-11

8.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

9.  Transplacental infection and embryonic death following maternal exposure to porcine parvovirus near the time of conception.

Authors:  W L Mengeling; P S Paul; T T Brown
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574
  9 in total
  9 in total

1.  Comparison of 17 isolates of the human parvovirus B 19 by restriction enzyme analysis. Brief report.

Authors:  F Morinet; J D Tratschin; Y Perol; G Siegl
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  The human parvovirus. Brief review.

Authors:  M J Anderson; J R Pattison
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

Review 3.  In vitro evidence of drug action in aplastic anemia.

Authors:  P C Vincent
Journal:  Blut       Date:  1984-07

4.  Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

Authors:  L J Anderson; C Tsou; R A Parker; T L Chorba; H Wulff; P Tattersall; P P Mortimer
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

5.  Parvovirus infection associated with aplastic crisis in a patient with HEMPAS.

Authors:  N C West; R E Meigh; M Mackie; M J Anderson
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

6.  Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

Authors:  B J Cohen; P P Mortimer; M S Pereira
Journal:  J Hyg (Lond)       Date:  1983-08

7.  Parvovirus infection in a family associated with aplastic crisis in an affected sibling pair with hereditary spherocytosis.

Authors:  D H Green; A J Bellingham; M J Anderson
Journal:  J Clin Pathol       Date:  1984-10       Impact factor: 3.411

8.  Hypothesis: the aplastic crisis of hereditary spherocytosis is due to a single transmissible agent.

Authors:  P P Mortimer
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

9.  Oscillatory fluctuations in the incidence of infectious disease and the impact of vaccination: time series analysis.

Authors:  R M Anderson; B T Grenfell; R M May
Journal:  J Hyg (Lond)       Date:  1984-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.